LL37 (5mg)

Mechanism of Action: How LL-37 (5mg) Works

LL-37 supports both innate immune defense and tissue recovery:

• Membrane Disruption of Pathogens: Destroys harmful microbes directly
• Immune Activation Modulation: Enhances immune coordination without overactivation
• Biofilm Breakdown: Helps disrupt microbial defense layers
• Angiogenesis & Tissue Repair: Promotes improved healing environments
• Barrier Integrity Support: Strengthens epithelial and mucosal protection

This makes LL-37 valuable for complex immune and recovery scenarios.

Clinical Dosing Guide for Providers

For licensed medical professionals only.

Suggested Dosage

• Typical Range: 100–500mcg 2–3x weekly
• Duration: 4–8+ weeks depending on therapeutic goals

Administration Notes

• Route: Subcutaneous injection or provider-directed targeted administration
• Common Clinical Stacks:
• BPC-157 — synergistic wound and GI repair
• TA1 — immune-strength enhancement
• TB-500 — connective tissue recovery

Reconstitution & Storage

• Reconstitute with bacteriostatic water
• Refrigerate after mixing
• Stability ~30 days refrigerated

Ideal Candidate Profile

Potentially Good Candidates

• Individuals with recurrent or chronic infection patterns
• Patients needing accelerated wound healing
• Those with compromised skin barrier or ulceration
• Gut barrier dysfunction cases

Use With Caution

• Autoimmune conditions — immune monitoring recommended
• Hyperinflammatory disorders — dose titration required

Potential Side Effects

Generally mild:

• Injection-site redness or warmth
• Temporary fatigue
• Mild inflammatory flare during microbial die-off

Clinical supervision is required due to immune-modulating activity.

Frequently Asked Questions

1. What is LL-37 used for?
Immune defense support and advanced tissue healing.

2. Is it an antibiotic?
No — it is a natural antimicrobial peptide, not a drug-class antibiotic.

3. Does it help with skin healing?
Yes — frequently used for wounds, ulcers, and dermatologic recovery.

4. Can it fight viral or fungal infections?
Yes — broad-spectrum antimicrobial activity.

5. How quickly does it work?
Healing and immune improvement may appear within 2–4 weeks.

6. Does it help gut health?
It may support mucosal immunity and barrier function.

7. Is it safe long term?
Typically — with appropriate provider oversight.

8. Can it be combined with TA1 or BPC-157?
Common — synergistic immune + repair benefits.

9. Will LL-37 overstimulate immunity?
Generally no — proper dosing helps maintain balance.

10. How is it stored?
Refrigerated post-reconstitution.

LL-37 vs Similar Peptides

• Vs BPC-157:
  LL-37 is antimicrobial + immune-driven; BPC focuses on repair.
• Vs TA1:
  TA1 strengthens immune function; LL-37 actively combats pathogens.
• Vs TB-500:
  TB-500 supports structural healing; LL-37 adds infection control.

Research & Evidence Overview

Studies support its role in:

• Antimicrobial defense
• Chronic and acute wound recovery
• Biofilm disruption
• Immune-response coordination
• Mucosal protection

A growing therapeutic option in immune and regenerative medicine.

Product & Purity Assurance

99% purity

• COA + endotoxin tested
• cGMP pharmaceutical standards
• Provider-exclusive dispensing

Legal & Medical Disclaimer

For licensed medical professionals only. Not intended to diagnose, treat, or cure any condition.